Add to Calendar
4/11/2019 8:00:00 AM
4/11/2019 10:00:00 AM
Two Sides of the Same Coin: Building Fruitful Collaborations between Academia & Pharma
The translation of medically relevant academic inventions into medicines that could transform public health has been notoriously difficult, stemming largely from differences between academia and the pharmaceutical industry. Like two sides of the same coin, they are very closely related but with key differences that are important to know. The goal of this forum is to build a shared understanding of both sides of the spectrum. Our panel will take a creative approach to reveal the primary needs of each party as well as the frustrations and barriers that prevent universities and pharma from fruitful collaborations.
MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Executive Director, Digital Medicine & Translational Imaging - Pfizer
Robert “Joe” Mather is an Executive Director in Pfizer’s Early Clinical Development Organization. Joe has over twenty years of pharmaceutical research and clinical development experience. Joe joined the Digital Medicine team two years ago after tenures with both Pfizer and Astra Zeneca’s Neuroscience organizations. Joe now leads a group of translational scientists, engineers and project managers engaged in the development of novel digital biomarkers in support of Pfizer’s clinical development portfolio as the head of the Advanced Science and Collaboration’s group in Digital Medicine and Translation Imaging.